Asthma Clinical Trial
Official title:
Feasibility of a Clinician Training Program to Improve Patient-provider Communication in the Presence of Health IT Systems in the Exam Room
The investigators propose to modify and expand the internationally-recognized evidence-based Physician Asthma Care Education (PACE) program to make it a suitable tool for training primary care clinicians on the effective use of EHRs at the point of care. The investigators will first develop the EHR edition of PACE (EHR-PACE) through literature and expert review of best practices for clinicians interacting with patients in the presence of computer systems in the exam room. They will then establish the feasibility and potential impact of EHR-PACE via a randomized design on 125 patients of 20 physicians who receive the intervention on the following outcomes via survey 3 and 6 months post-intervention: patient satisfaction with the physician's performance, asthma control, and asthma-related quality of life. Outcomes will be assessed on patients, but physicians will receive the intervention. Patients will not know which arm their doctor was randomized to. The pilot trial will compare two groups of primary care physicians who see patients with asthma in clinics equipped with certified EHRs. It is hypothesized that patients of physicians who receive EHR-PACE training will achieve better outcomes compared to physicians who do not receive EHR-PACE.
Failure in clinician-patient communication, lack of clarity regarding clinical treatment
priorities, and more recently, ineffective use of health IT systems in exam rooms are
associated with deficits in achieving chronic disease management goals, and increased
healthcare utilization and costs. Strategies for communicating with patients in exam rooms in
the presence of electronic health records (EHR) have been described in the literature.
Whether such strategies are reaching clinicians and demonstrating positive health outcomes is
unclear. The investigators propose to develop and test the feasibility on patient outcomes of
an interactive training module that teaches clinicians best practices for communicating with
patients in the presence of computer systems in the exam room (specifically EHRs). They
propose to modify and expand the internationally-recognized evidence-based Physician Asthma
Care Education (PACE) program to make it a suitable tool for training primary care clinicians
on the effective use of EHRs at the point of care. The PACE program is based on concepts and
skills for strengthening communication and patient-clinician relationships through behavior
change principles that are highly applicable to patients with asthma and has potential for
specific application to EHR use in clinical practice. The investigators will first develop
the EHR edition of PACE (EHR-PACE) through literature and expert review of best practices for
clinicians interacting with patients in the presence of computer systems in the exam room.
They will then establish the feasibility and potential impact of EHR-PACE via a randomized
design on 125 patients of 20 physicians who receive the intervention on the following
outcomes via survey 3 and 6 months post-intervention: patient satisfaction with the
physician's performance, asthma control, and asthma-related quality of life. Outcomes will be
assessed on patients, but physicians will receive the intervention.Patients will not know
which arm their doctor was randomized to.The pilot trial will compare two groups of primary
care physicians who see patients with asthma in clinics equipped with certified EHRs. It is
hypothesized that patients of physicians who receive EHR-PACE training will achieve better
outcomes compared to physicians who do not receive EHR-PACE.
EHR-PACE developed in this study is expected to have a high degree of relevance for improving
the patient-provider communication skills of clinicians who see a wide range of patients in a
variety of practice settings that have now integrated EHRs. Given that PACE can achieve
dramatic outcomes within only two, 2-hour sessions, EHR-PACE has the potential to become an
invaluable training tool to busy clinicians if proven feasible and effective. Ultimately,
this work has potential for a high degree of impact.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04624425 -
Additional Effects of Segmental Breathing In Asthma
|
N/A | |
| Terminated |
NCT04410523 -
Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma
|
Phase 2 | |
| Active, not recruiting |
NCT03927820 -
A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)
|
N/A | |
| Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
| Recruiting |
NCT03694158 -
Investigating Dupilumab's Effect in Asthma by Genotype
|
Phase 4 | |
| Terminated |
NCT04946318 -
Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma
|
Phase 2 | |
| Completed |
NCT04450108 -
Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients
|
N/A | |
| Completed |
NCT03086460 -
A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH)
|
Phase 2 | |
| Completed |
NCT01160224 -
Oral GW766944 (Oral CCR3 Antagonist)
|
Phase 2 | |
| Completed |
NCT03186209 -
Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE)
|
Phase 3 | |
| Completed |
NCT02502734 -
Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma
|
Phase 3 | |
| Completed |
NCT01715844 -
L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics
|
Phase 1 | |
| Terminated |
NCT04993443 -
First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036
|
Phase 1 | |
| Completed |
NCT02787863 -
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
|
Phase 4 | |
| Recruiting |
NCT06033833 -
Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study
|
Phase 2 | |
| Completed |
NCT03257995 -
Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.
|
Phase 2 | |
| Completed |
NCT02212483 -
Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients
|
N/A | |
| Recruiting |
NCT04872309 -
MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
|
||
| Withdrawn |
NCT01468805 -
Childhood Asthma Reduction Study
|
N/A | |
| Recruiting |
NCT05145894 -
Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device
|